NCT07124000

DESTINY-PANTUMOUR04

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-09-18Est. Completion: 2028-03-30

Enrollment target: 100 participants

Locations

Research Site, Birmingham, Alabama, United States
Research Site, Bullhead City, Arizona, United States
Research Site, Casa Grande, Arizona, United States
Research Site, San Diego, California, United States
Research Site, Boulder, Colorado, United States
Research Site, Coral Springs, Florida, United States
Research Site, St. Petersburg, Florida, United States
Research Site, West Palm Beach, Florida, United States
Research Site, Decatur, Illinois, United States
Research Site, Topeka, Kansas, United States
Research Site, Durham, North Carolina, United States
Research Site, Wilson, North Carolina, United States
Research Site, Canton, Ohio, United States
Research Site, Maumee, Ohio, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Nashville, Tennessee, United States
Research Site, Dallas, Texas, United States

Other microbiome trials you might be interested in

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch StudiesENROLLING_BY_INVITATION

MelanomaAdenocarcinomaCarcinoma NOSNeuroendocrine Tumors

Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from part…

Bethesda, United States

View Trial →

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerPhase 3Recruiting

Locally Advanced Cervical AdenocarcinomaLocally Advanced Cervical Adenosquamous CarcinomaLocally Advanced Cervical Squamous Cell CarcinomaStage IIIA Cervical Cancer FIGO 2018Stage IIIB Cervical Cancer FIGO 2018

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.